Delayed splenic rupture in a haemophiliac von Thomas, D. W., Atoyebi, W., McElwaine‐Johnn, H. A., Giangrande, P. L. F.

Volltext

Delayed splenic rupture in a haemophiliac: D.W. Thomas et al von Thomas, D. W., Atoyebi, W., McElwaine-Johnn, H. A., Giangrande, P. L. F.

Volltext

Delayed splenic rupture in a haemophiliac von Thomas, D. W., Atoyebi, W., McElwaine-Johnn, H. A., Giangrande, P. L. F.

Volltext

Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors von Tsimberidou, Apostolia M, Beer, Philip A, Cartwright, Carrie A, Haymaker, Cara, Vo, Henry H, Kiany, Simin, Cecil, Alexander R L, Dow, James, Haque, Kemal, Silva, Franck A, Coe, Lucy, Berryman, Helen, Bone, Elisabeth A, Nogueras-Gonzalez, Graciela M, Vining, David, McElwaine-Johnn, Hilary, Wistuba, Ignacio I

Volltext

612P - SPICE, a phase I study of enadenotucirev in combination with nivolumab in tumours of epithelial origin: Analysis of the metastatic colorectal cancer patients in the dose esc... von Fakih, M.G., Wang, D., Harb, W., Rosen, L., Mahadevan, D., Berlin, J.D., Basciano, P., Brown, R., Arogundade, O., Cox, C., Genova, G Di, Krige, D., McElwaine-Johnn, H.

Volltext

SPICE, a phase I study of enadenotucirev in combination with nivolumab in tumours of epithelial origin: Analysis of the metastatic colorectal cancer patients in the dose escalation... von Fakih, M.G., Wang, D., Harb, W., Rosen, L., Mahadevan, D., Berlin, J.D., Basciano, P., Brown, R., Arogundade, O., Cox, C., Genova, G Di, Krige, D., McElwaine-Johnn, H.

Volltext

Optimizing the tolerability of intravenous oncolytic viral immunotherapy administration: A sub-analysis of tolerability and cytokine data from the EVOLVE study of enadenotucirev (E... von McElwaine-Johnn, H., Pover, G., Alvis, S., Brown, R., Fisher, K., Morris, C., Champion, B., Beadle, J.

Volltext

1031P - OCTAVE: A phase I study of enadenotucirev, an oncolytic group B adenovirus, in combination with weekly paclitaxel in platinum-resistant epithelial ovarian cancer von McNeish, I.A., Moreno, V., Jayson, G., Roxburgh, P., Ginesta, M P Barretina, Garcia-Donas, J., Torres, A Anton, Michael, A., Brown, R., Krige, D., Bendall, J., Di Genova, G., McElwaine-Johnn, H.

Volltext

612PSPICE, a phase I study of enadenotucirev in combination with nivolumab in tumours of epithelial origin: Analysis of the metastatic colorectal cancer patients in the dose escala... von Fakih, M G, Wang, D, Harb, W, Rosen, L, Mahadevan, D, Berlin, J D, Basciano, P, Brown, R, Arogundade, O, Cox, C, Genova, G Di, Krige, D, McElwaine-Johnn, H

Volltext

OCTAVE: A phase I study of enadenotucirev, an oncolytic group B adenovirus, in combination with weekly paclitaxel in platinum-resistant epithelial ovarian cancer von McNeish, I.A., Moreno, V., Jayson, G., Roxburgh, P., Ginesta, M P Barretina, Garcia-Donas, J., Torres, A Anton, Michael, A., Brown, R., Krige, D., Bendall, J., Di Genova, G., McElwaine-Johnn, H.

Volltext

1031POCTAVE: A phase I study of enadenotucirev, an oncolytic group B adenovirus, in combination with weekly paclitaxel in platinum-resistant epithelial ovarian cancer von McNeish, I A, Moreno, V, Jayson, G, Roxburgh, P, Ginesta, M P Barretina, Garcia-Donas, J, Torres, A Anton, Michael, A, Brown, R, Krige, D, Bendall, J, Di Genova, G, McElwaine-Johnn, H

Volltext

A mechanism of action study of intra-tumoral or intravenous dosing of enadenotucirev, an oncolytic adenovirus in patients with colon, lung, bladder and renal carcinoma undergoing r... von Garcia-Carbonero, R., Boni, V., Duran, I., Gil, M., Espinosa, M., Salazar, R., Cubillo, A., Jurado, M., Champion, B., Alvis, S., Fisher, K., Beadle, J., Pover, G., McElwaine-Johnn, H., Ellis, C., Blanc, C., Calvo, E.

Volltext